Latest News about Psilocybin program
Recent news which mentions Psilocybin program
From Benzinga
Filament Health Uplisting To NASDAQ In A $210M SPAC Deal
July 19, 2023
From Benzinga
Compatibility Of Psilocybin & SSRIs For Depression, COMPASS Looks At 'Psychedelic-Assisted Therapies'
July 18, 2023
Tickers
CMPS
From Benzinga
Filament Supplies Botanical Psilocybin To Canadian Researchers, Inks Global Licensing Deal
July 07, 2023
Tickers
FLHLF
From Benzinga
Wesana Shareholders Vote For Psilocybin And CBD Therapy Asset Sales To Lucy Scientific
June 12, 2023
From Benzinga
From Benzinga
From Benzinga
Colorado Media Buzz On Psychedelic Mushroom Businesses, This Company Offers 'Top Rare' Strains
June 02, 2023
From Benzinga
UCSF Clinical Trial Shows Promising Results For Naturally-Sourced Psilocybin And Psilocin
May 30, 2023
Tickers
FLHLF
From Benzinga
From Benzinga
Washington State Psychedelics Trial Targets PTSD And Alcohol Use Disorder, Mandated By Law
May 23, 2023
From Benzinga
This Biotech Company Discovers What May Be The First New Compounds Of Psilocybin In History
May 19, 2023
From Benzinga
EXCLUSIVE: Lessons From Psychedelics Markets Through Business, Legal And Reciprocity Lenses
May 12, 2023
Tickers
BWVI
From Benzinga
COMPASS Pathways Reports Q1 2023: Financials, Commercial Groundwork And Ongoing Phase 3 Trials
May 11, 2023
Tickers
CMPS
From Benzinga
International IP Claims On Novel Psychedelic Fungi Biomass Manufacturing Gets Prelim Acceptance
May 03, 2023
From Benzinga
Psyched: Canada's Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More
April 05, 2023
From Benzinga
Therapists At Mass General Hospital Prepared To Assist IBS Patients With Psilocybin Therapy
April 04, 2023
Tickers
TRYPF
From Benzinga
Filament Health: 2022 Financials And Operational Highlights From Creator Of The Ayahuasca Pill
April 03, 2023
From Benzinga
COMPASS Pathways: New Data & Insight On Psilocybin Therapy For Treatment-Resistant Depression
March 14, 2023
Tickers
CMPS
From Benzinga
Australia Receives First Batch Of Clinical-Grade Psilocybin From Mindset Pharma And PharmAla
March 06, 2023
From Benzinga
COMPASS Pathways Shares Q4 & Year-End 2022 Financials, Advances Phase 3 Psilocybin Trials
February 28, 2023
Tickers
CMPS
From Benzinga
2C-B Vs. Psilocybin: New Study Shares Insightful Trial Results On The Mescaline-Derived Psychedelic's Effects
February 21, 2023
From Benzinga
State-Level Psychedelics In 2023: Oklahoma Introduces Research Bill, Washington Amends And Passes Measure
February 17, 2023
From Benzinga
Supply Partnerships: Filament's Psilocybin Trial In Canada, PharmAla's MDMA Program In Australia
February 14, 2023
Tickers
FLHLF
From Benzinga
From Benzinga
Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
February 13, 2023
From Benzinga
Testing Psychedelics Efficacy On 'Psychiatry's Blind Spot': Latest King's College Trial
February 13, 2023
From Benzinga
How Do Psilocybin And MDMA Work Together? This Proposed Experiential Study Is Set To Find Out
February 09, 2023
Tickers
OPTHF
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.